Verizon beats profit, revenue estimates on more subscribers
Verizon Communications Inc reported better-than-expected quarterly profit and revenue on Tuesday, as the No. 1 U.S. wireless carrier attracted more subscribers with unlimited data plans.
Stock futures rise as Alphabet gains, lifts FAANG stocks
U.S. stock index futures rose on Tuesday, as Alphabet’s strong results lifted other high-growth technology companies, adding to a robust earnings season in the backdrop of a U.S.-China trade war and a strengthening dollar.
Biogen beats estimates on Spinraza sales, raises forecast
Biogen Inc reported a better-than-expected quarterly profit on Tuesday and raised its forecast for 2018 adjusted earnings, driven by strong demand for its rare muscle disease treatment Spinraza, sending its shares up more than 5 percent.
China’s caffeine war: Fast-growing Luckin brews up a threat to Starbucks
Qian Zhiya may be Starbucks’ worst nightmare.
EU fines Philips, Asus, Pioneer, Denon & Marantz total 111 million euros
EU antitrust authorities handed down a total fine of 111.2 million euros ($130.1 million) to Philips , Pioneer , Asus and Denon & Marantz on Tuesday for fixing online resale prices.
Eli Lilly spins off animal health unit, second quarter beats
Eli Lilly and Co on Tuesday said it would spin off its Elanco animal health business into a publicly-traded company and posted better-than-expected quarterly profit helped by demand for its diabetes drugs Trulicity and Humalog.
Bitcoin surpasses $8,000 to hit two-month high
Bitcoin, the world’s best-known cryptocurrency, shot past $8,000 on Tuesday for the first time in two months on signs of growing institutional interest in virtual coins.
Harley-Davidson profit tops estimates on overseas sales
Harley-Davidson Inc’s profit topped Wall Street estimates on Tuesday for the sixth straight quarter, as sales of its bikes overseas edged up, although the company warned that new EU tariffs would squeeze its operating margins.
Biogen quarterly sales rise 9 percent
Biogen Inc reported a 9 percent rise in quarterly revenue on Tuesday, helped by demand for its spinal muscular atrophy drug Spinraza.
Eli Lilly posts quarterly loss
Eli Lilly and Co posted a second-quarter loss on Tuesday, hurt by acquisition-related charges to the tune of $1.62 billion.
